|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Harpoon Therapeutics, Inc. (HARP) |
|
|
$0.89 0.00 (0.00%) as of 4:30 Fri 9/1
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
32,670,000 |
| Market
Cap: |
29.20(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.546 - $1.06 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Harpoon Therapeutics is a clinical-stage immunotherapy company. Co.'s Tri-specific T cell Activating Construct (TriTACs) product candidates include: HPN328, which is for the treatment of small cell lung cancer and other Delta-like canonical Notch ligand 3-expressing tumors; HPN217, which is for the treatment of multiple myeloma; and HPN536, which is for the treatment of ovarian and pancreatic cancers and other mesothelin- expressing solid tumors. Co.'s proprietary TriTAC product candidate is HPN601, which targets the epithelial cell adhesion molecule and is being developed for the treatment of multiple solid tumor indications.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
21,397,205 |
24,484,205 |
24,484,205 |
24,494,205 |
| Total Buy Value |
$492,135,715 |
$492,135,715 |
$492,135,715 |
$502,135,715 |
| Total People Bought |
1 |
3 |
3 |
3 |
| Total Buy Transactions |
1 |
4 |
4 |
5 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Eastland Julia Marie |
President and CEO |
• • – |
2024-03-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(269,381) |
0 |
|
- |
|
| Eastland Julia Marie |
President and CEO |
• • – |
2024-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
31,250 |
269,381 |
|
- |
|
| Chin Mark |
|
– • – |
2024-03-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,224) |
0 |
|
- |
|
| Bailes Joseph S |
|
– • – |
2024-03-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,000) |
0 |
|
- |
|
| Lanza Frank J |
Principal Fin. & Acctng Ofc. |
• – – |
2024-03-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(18,734) |
0 |
|
- |
|
| Hunt Ronald |
|
– • • |
2024-03-11 |
4 |
D |
$0.00 |
$0 |
I/I |
(10,000) |
0 |
|
- |
|
| Hunt Ronald |
|
– • • |
2024-03-11 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,859,169) |
0 |
|
- |
|
| Hunt Ronald |
|
– • • |
2024-03-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,224) |
0 |
|
- |
|
| Walker Luke Nathaniel |
Chief Medical Officer |
• – – |
2024-03-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(135,000) |
0 |
|
- |
|
| Lathi Vijay K |
|
– • • |
2024-03-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,000) |
0 |
|
- |
|
| Lathi Vijay K |
|
– • • |
2024-03-11 |
4 |
D |
$0.00 |
$0 |
I/I |
(395,783) |
0 |
|
- |
|
| Lathi Vijay K |
|
– • • |
2024-03-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,463,386) |
0 |
|
- |
|
| Merck & Co Inc |
|
– – • |
2024-03-11 |
4 |
B |
$23.00 |
$492,135,715 |
I/I |
21,397,205 |
1,000 |
0.01 |
- |
|
| Drachman Jonathan G |
|
– • – |
2024-03-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,415) |
0 |
|
- |
|
| Robbins Andrews R |
|
– • – |
2024-03-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,000) |
0 |
|
- |
|
| Silvernail Lauren P |
|
– • – |
2024-03-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,000) |
0 |
|
- |
|
| Myers Scott Dunseth |
|
– • – |
2024-03-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(22,665) |
0 |
|
- |
|
| Chin Mark |
|
– • – |
2024-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
424 |
13,224 |
|
- |
|
| Hunt Ronald |
|
– • • |
2024-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
424 |
13,224 |
|
- |
|
| Drachman Jonathan G |
|
– • – |
2024-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
415 |
5,415 |
|
- |
|
| Eastland Julia Marie |
President and CEO |
• • – |
2024-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
178,500 |
232,003 |
|
- |
|
| Walker Luke Nathaniel |
Chief Medical Officer |
• – – |
2024-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
115,000 |
135,000 |
|
- |
|
| Lanza Frank J |
Principal Fin. & Acctng Ofc. |
• – – |
2024-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
18,362 |
|
- |
|
| Hunt Ronald |
|
– • • |
2024-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,072 |
12,801 |
|
- |
|
| Chin Mark |
|
– • – |
2024-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,072 |
12,801 |
|
- |
|
213 Records found
|
|
Page 1 of 9 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
